UC	Ulcerative Colitis
CS	Corticosteroid
PMS	Partial Mayo Score
5-ASA	5-Aminosalicylates
JAK	Janus Kinase
TNF	Tumor Necrosis Factor
SC	Subcutaneous
RCT	Randomized Clinical Trials
CEP	Ethics Committee
STROBE	STrengthening the Reporting of OBservational studies in Epidemiology
ANVISA	Brazilian Health Regulatory Agency
BMI	Body Mass Index
EIM	Extraintestinal Manifestations
CRP	C-reactive Protein
FC	Fecal Calprotectin
MES	Mayo Endoscopic Subscore
SD	Standard Deviation
IQR	Interquartile Range
CI	Confidence Interval
RR	Relative Risk
CV	Coefficient of Variation
IFX	Infliximab
ADA	Adalimumab
VEDO	Vedolizumab
UST	Ustekinumab
CTZ	Certolizumab pegol
mg	milligram
dL	deciliter
µg	microgram
g	gram
HR	Hazard Ratio